May 28, 2014

Glucose Management System Improves Standard of Care at Sentara

Hospitals have often had trouble managing patients with hyperglycemia and hypoglycemia. To help remedy that problem, Sentara Healthcare has ushered in a new standard of care in glucose management.

In 2008, Sentara saw several of its patients die due to poor management of their diabetes. There were several devastating events of prolonged hypoglycemia that resulted in permanent brain damage for patients, says Paul Chidester, M.D., vice president of medical affairs at the Va.-based Sentara Norfolk General Hospital within the health system. Sentara had reached a point when it knew it needed to do something to improve the care of its diabetes patients. “We sort of tolerated poor control of hyperglycemia and viewed episodes of hypoglycemia as a rite of passage of being in the hospital,” Chidester admits. [We said] poor control happens, just live with it. We then realized the negative impact that had on our patients, and decided that it had to change.”

May 22, 2014

Duke University School of Nursing Study Shows Major Tertiary Hospital Saves More Than 72 Minutes Per Nurse While Improving Clinical Outcomes Using eGlycemic Management System

Time and motion study poster presented during AACE shows increased efficiency in insulin management and improved rates of hyperglycemia and hypoglycemia.

Glytec, a clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control, is pleased to share the results of a late-breaking poster that was presented at the American Association of Clinical Endocrinologists (AACE) 23rd Annual Scientific and Clinical Congress. The poster, “New Interfaces for eGlycemic Management System Saves Nursing Time and Improves Patient Outcomes: Time and Motion Nursing Study,” is based on a study that shows a reduction in nursing time and improvements in both patient outcomes and nurse satisfaction through the integration of Glytec’s eGlycemic Management System® (eGMS®).

May 16, 2014

E-Check of Sugar Aids in Inpatient Hypoglycemia Control

Electronic monitoring of blood sugar levels may diminish hypoglycemia and reduce length of stay in hospitalized diabetic ketoacidosis (DKA) patients, researchers reported here.

In one study, patients monitored with the Glucommander system reduced episodes of hypoglycemia by 56%, Joseph Aloi, MD, director of the Strelitz Diabetes Center at Eastern Virginia Medical School in Norfolk, and colleagues reported at the American Association of Clinical Endocrinologists meeting here. In a second study, they showed that the same system reduced the overall hospital length of stay by nearly 2 1/2 days in patients with diabetic ketoacidosis.

May 13, 2014

Glytec Announces Late Breaking Abstracts Accepted for Poster Presentations at American Association of Clinical Endocrinologists 23rd Annual Scientific & Clinical Congress

Conducted by researchers from Duke University School of Nursing, Piedmont Healthcare, Jackson Madison County General Hospital, Sentara Health System and Eastern Virginia Medical School, the poster presentations will highlight research results evaluating Glytec’s eGlycemic Management System® in three leading acute care hospitals.

Glytec, LLC, a clinical information technology company dedicated to the mission of improving insulin management and glycemic control, announced today that several late breaking abstracts featuring the company’s eGlycemic Management System have been accepted for poster presentations at the American Association of Clinical Endocrinologists 23rd Annual Scientific and Clinical Congress, taking place from May 14 – May 18, 2014, in Las Vegas. The posters will be displayed from 9:30 a.m. to 1:00 p.m. on Saturday, May 17th in the General Poster Sessions in the exhibit hall. Presentations by the lead authors will occur from 9:45 a.m. to 11:00 a.m. on Saturday, May 17th.

Eastern Virginia Medical School Study Indicates Major Glycemic Improvement in Subcutaneous Basal Bolus Insulin Delivery Using eGlycemic Management System

Poster presented during AACE shows improved outcomes using Glytec’s subcutaneous insulin dosing solution versus traditional basal bolus insulin therapy.

Glytec, a clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control, is pleased to share the results of a late-breaking poster that was presented at the American Association of Clinical Endocrinologists (AACE) 23rd Annual Scientific and Clinical Congress. The poster is based on results experienced by Sentara Healthcare during the first 30 days after using Glytec’s Glucommander™ SubQ to manage subcutaneous Basal Bolus Insulin (BBI) therapy. The poster was presented by Joseph Aloi, MD, clinical director of the Strelitz Diabetes Center at Eastern Virginia Medical School, during the Congress’s general poster session.

May 7, 2014

Sentara Healthcare Ushers in a New Standard of Care in Glucose Management

Leading hospital system achieves dramatic reductions in occurrences of hyperglycemia and hypoglycemia, reduces length of stay.

Sentara Healthcare, a 12-hospital, not-for-profit health system serving Virginia and northeastern North Carolina, widely recognized for clinical excellence and IT innovation, today announced that they have achieved dramatic improvements in inpatient glucose management through the utilization of the eGlycemic Management System® (eGMS®), developed by Glytec.

May 14, 2013

Mountain States Health Alliance Achieves Dramatic Improvements in Glycemic Control with the Comprehensive Insulin-dosing Software Platform from Glytec

Thirteen-hospital system serving 29 counties in Tennessee, Virginia, Kentucky, and North Carolina applauds the solution for its integration, usability, and impact on patient care.

Glytec, a clinical information technology company dedicated to glycemic management solutions for hospitals and patients, today announced that Mountain States Health Alliance (MSHA) has experienced unprecedented clinical results in just the first 60 days of use of the inpatient glycemic control platform, Glucommander™.

May 22, 2012

Glytec Adds Pediatric Insulin Dosing to its IV and SubQ FDA Clearances

Glytec announced today that its Glucommander™ 2.0 Enterprise platform has been cleared by the FDA for pediatric use, ages 2 – 17.

Glytec’s Glucommander™ was the first insulin dosing software to be cleared for adult (ages 18+) intravenous use; it is the only company to achieve specific clearance for subcutaneous use, and now it is the only company cleared to offer this technology to hospitals caring for children.

May 2, 2012

Glytec Achieves ISO Certification

Glytec is the first company to achieve this medical device certification in the glycemic management product space.

Glytec, LLC, a privately held medical software company, announced that it has achieved the ISO 13485:2003 Certification for its quality management and assurance processes for the safe design, production and installation of Glucommander 2.0 Enterprise software.

September 19, 2011

GlucoTec, Inc. Completes Series A Preferred Stock Financing

Glytec will use the capital primarily to expand its direct US sales force, increase its international presence and advance research and development.

GlucoTec, Inc., the privately-held parent company of Glytec, LLC, today announced that it has completed a Series A Preferred Stock financing totaling $8,273,078.

May 11, 2011

Glytec Earns U.S. Department of Commerce Safe Harbor Certification for European Union

Glytec, a world leader in glycemic management solutions, has announced that it has achieved the U.S. Department of Commerce Safe Harbor Certification.

The Safe Harbor provides a legal framework allowing for protection of personal data generated from European countries and the safe transfer of data to the U.S. By certifying to the Safe Harbor, Glytec had demonstrated compliance with the Safe Harbor privacy principles accepted by all 27 member states of the European Union.

March 7, 2011

West Tennessee Healthcare Accelerates Optimum Inpatient Glucose Control with Glucommander Plus

The Glucommander Plus software provides healthcare professionals with individualized insulin dosing requirements for hospitalized patients.

Dave Roberts, MD, Vice President and Chief Medical Officer at West Tennessee Healthcare recently conducted a webinar presenting a systems approach to inpatient glucose control using the Glucommander Plus software from Glytec. The software includes many safety guardrails including predictive warning and alerts, a fully-integrated and real-time reporting engine, and precision bolus dosing of meal-time insulin.

November 1, 2010

Glytec Insulin Dosing Software Now Compatible with BlackBerry, Android, and iPhone

The G+ Enterprise Edition software is now compatible with select Android, BlackBerry, and iPhone devices, including the new iPhone 4 and iPad.

Glytec, LLC, a leader in glycemic management solutions, announced today that it has released a new enhancement to its inpatient blood glucose management software. The G+ Enterprise Edition software provides both intravenous and subcutaneous dosing recommendations of insulin and glucose and can be accessed from any computer within a hospital’s network. Users with mobile devices can now access real-time patient information, allowing for better monitoring of insulin dosing and blood glucose levels.